The purpose of this chapter is to establish the requirements for epinephrine autoinjectors and anaphylaxis training for employees and representatives of authorized entities under RCW 70.54.440.

The definitions in this section apply throughout this chapter unless the context clearly indicates otherwise.

(1) "Administer" or "administration" means the direct application of an epinephrine autoinjector to the body of an individual.

(2) "Authorized entity" means any entity or organization at or in connection with which allergens capable of causing anaphylaxis may be present including, but not limited to, restaurants, recreation camps, youth sports leagues, amusement parks, colleges, universities, and sports arenas.

(3) "Department" means the Washington state department of health.

(4) "Dispenser" means a health care provider who may dispense epinephrine autoinjectors pursuant to a prescription issued in the name of an authorized entity.

(5) "Epinephrine autoinjector" means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.

(6) "Prescriber" means an authorized health care provider allowed by law to prescribe an epinephrine autoinjector in the course of professional practice.

(7) "Training provider" means an organization, entity, business, or individual who provides epinephrine autoinjector and anaphylaxis training.

(8) "Self-administration" means a person's discretionary use of an epinephrine autoinjector on themselves.

Prior to prescribing or dispensing an epinephrine autoinjector to an authorized entity, a prescriber or dispenser may require proof of epinephrine autoinjector and anaphylaxis training.

An employee or representative of an authorized entity shall complete an epinephrine autoinjector and anaphylaxis training by an approved training provider, as defined in WAC 246-570-040, prior to storing, maintaining, providing or administering an epinephrine autoinjector made available by an authorized entity.

(1) Epinephrine autoinjector and anaphylaxis training must be conducted by:

(a) A nationally recognized organization experienced in training laypersons in emergency health treatment. For the purposes of this section, the American Red Cross anaphylaxis and epinephrine autoinjector training course is an approved training provider; or

(b) A training provider approved by the department must meet the following requirements:

(i) Training content must meet the requirements in WAC 246-570-050;

(ii) Each individual providing training shall have:

(A) Knowledge of epinephrine autoinjector and anaphylaxis; and

(B) Experience delivering training in epinephrine autoinjector administration, and anaphylaxis causes and symptoms.

(2) A training provider shall issue a certificate to each person who successfully completes training. The certificate must include:

(a) The training provider's name, address and other contact information;

(b) Name of the training participant;

(c) Date the training was completed;

(d) Expiration date, if any; and

(e) The name of the training or other information indicating that the training was in anaphylaxis and epinephrine autoinjector storage, maintenance, and administration.

(1) Epinephrine autoinjector and anaphylaxis training may be conducted online or in person and at a minimum, must include:

(a) Techniques on how to recognize symptoms of severe allergic reactions, including anaphylaxis;

(b) Standards and procedures for the storage and administration of an epinephrine autoinjector;

(c) Emergency follow-up procedures;

(d) The use and administration of an epinephrine autoinjector with adults and children; and

(e) An assessment to ensure the participant gained competency in anaphylaxis and epinephrine autoinjector administration.

(2) Training must be based on current best practices.

(1) Each authorized entity must report to the department each incident when an employee or representative who holds a training certificate under WAC 246-570-030 administers or provides an epinephrine autoinjector to a person believed to be suffering from anaphylaxis.

(2) The incident report must be reported within five days of the incident.

(3) The incident report must be on a form or format provided by the department.

The secretary will consider for approval any training provider which meets the requirements as outlined in this chapter.

(1) An authorized representative of the training provider shall request approval on a form provided by the department.

(2) The training provider must submit documentation demonstrating that training content meets the requirements of WAC 246-570-050.

(3) Upon the evaluation of a complete application, the secretary will grant or deny approval.

(4) If the department notifies a training provider of the department's intent to deny, suspend or revoke approval, the training provider may request an adjudicative proceeding under chapter 246-10 WAC. A request for an adjudicative proceeding must be in writing, state the basis for contesting the adverse action, include a copy of the adverse notice and be served on and received by the department within twenty-eight days of the training provider's receipt of the adverse notice.